| Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin A López-Guillermo, L Colomo, M Jiménez, F Bosch, N Villamor, ... Journal of clinical oncology 23 (12), 2797-2804, 2005 | 381 | 2005 |
| Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy G Gutiérrez-García, T Cardesa-Salzmann, F Climent, E González-Barca, ... Blood, The Journal of the American Society of Hematology 117 (18), 4836-4843, 2011 | 371 | 2011 |
| Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia E Such, U Germing, L Malcovati, J Cervera, A Kuendgen, MG Della Porta, ... Blood, The Journal of the American Society of Hematology 121 (15), 3005-3015, 2013 | 344 | 2013 |
| MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy A Valera, A López-Guillermo, T Cardesa-Salzmann, F Climent, ... haematologica 98 (10), 1554, 2013 | 274 | 2013 |
| Independent impact of iron overload and transfusion dependency on survival and leukemic evolution in patients with myelodysplastic syndrome G Sanz, B Nomdedeu, E Such, T Bernal, M Belkaid, MT Ardanaz, V Marco, ... Blood 112 (11), 640, 2008 | 165 | 2008 |
| Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q M Mallo, J Cervera, J Schanz, E Such, G García-Manero, E Luno, C Steidl, ... Leukemia 25 (1), 110-120, 2011 | 160 | 2011 |
| The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular … E Gine, S Montoto, F Bosch, L Arenillas, S Mercadal, N Villamor, ... Annals of oncology 17 (10), 1539-1545, 2006 | 143 | 2006 |
| High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy TM Cardesa-Salzmann, L Colomo, G Gutierrez, WC Chan, ... Haematologica 96 (7), 996, 2011 | 138 | 2011 |
| Response to lenalidomide in myelodysplastic syndromes with del (5q): influence of cytogenetics and mutations M Mallo, M Del Rey, M Ibanez, MJ Calasanz, L Arenillas, MJ Larráyoz, ... British journal of haematology 162 (1), 74-86, 2013 | 115 | 2013 |
| Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition M Granell, X Calvo, A Garcia-Guiñón, L Escoda, E Abella, CM Martínez, ... Haematologica 102 (6), 1099, 2017 | 109 | 2017 |
| Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes L Senent, L Arenillas, E Luño, JC Ruiz, G Sanz, L Florensa haematologica 98 (4), 568, 2013 | 99 | 2013 |
| Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis J Broseus, L Florensa, E Zipperer, S Schnittger, L Malcovati, ... Haematologica 97 (7), 1036, 2012 | 96 | 2012 |
| Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era G Gutierrez-Garcia, L Colomo, N Villamor, L Arenillas, A Martínez, ... Leukemia & lymphoma 51 (7), 1225-1232, 2010 | 58 | 2010 |
| Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q M Mallo, L Arenillas, B Espinet, M Salido, JM Hernández, E Lumbreras, ... Haematologica 93 (7), 1001-1008, 2008 | 51 | 2008 |
| Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia E Puigdecanet, B Espinet, JJ Lozano, L Sumoy, B Bellosillo, L Arenillas, ... Leukemia 22 (7), 1368-1376, 2008 | 50 | 2008 |
| Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients F Plancarte, A López‐Guillermo, L Arenillas, S Montoto, E Giné, ... European journal of haematology 76 (1), 58-63, 2006 | 48 | 2006 |
| Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry B Espinet, A Ferrer, B Bellosillo, L Nonell, A Salar, ... Clinical Cancer Research 20 (4), 1007-1019, 2014 | 47 | 2014 |
| Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing L Arenillas, M Mallo, F Ramos, K Guinta, E Barragan, E Lumbreras, ... Genes, Chromosomes and Cancer 52 (12), 1167-1177, 2013 | 47 | 2013 |
| Response to thalidomide in multiple myeloma: impact of angiogenic factors L Rosiñol, MT Cibeira, M Segarra, MC Cid, X Filella, M Aymerich, ... Cytokine 26 (4), 145-148, 2004 | 47 | 2004 |
| Grup per l’Estudi dels Limfomes de Catalunya I Balears (GELCAB) G Gutiérrez-García, T Cardesa-Salzmann, F Climent, E González-Barca, ... Gene-expression profiling and not immunophenotypic algorithms predicts …, 2011 | 45 | 2011 |
